Analyst Reco. Hims & Hers Health, Inc.

Equities

HIMS

US4330001060

Real-time Estimate Cboe BZX Other stock markets 03:44:40 2024-05-28 pm EDT			5-day change	1st Jan Change
19.08 ^USD	+13.00%		+7.35%	+111.80%

May. 22	Hims & Hers Health Insider Bought Shares Worth $1,951,763, According to a Recent SEC Filing	MT
May. 22	Hims & Hers Health Insider Sold Shares Worth $819,732, According to a Recent SEC Filing	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Hims & Hers Health Insider Bought Shares Worth $1,951,763, According to a Recent SEC Filing	May. 22	MT
Hims & Hers Health Insider Sold Shares Worth $819,732, According to a Recent SEC Filing	May. 22	MT
Canaccord Genuity Adjusts Price Target on Hims & Hers Health to $24 From $20, Maintains Buy Rating	May. 22	MT
Citigroup Downgrades Hims & Hers Health to Neutral From Buy With $20 Price Target	May. 22	MT
Social Buzz: Wallstreetbets Stocks Mostly Lower Premarket Wednesday; Hims & Hers Health, Tesla to Decline	May. 22	MT
Social Buzz: Wallstreetbets Stocks Mixed Pre-Bell; Hims & Hers Health to Advance, AMC Entertainment to Decline	May. 21	MT
Piper Sandler Adjusts Hims & Hers Health's Price Target to $13 From $11, Keeps Neutral Rating	May. 07	MT
Deutsche Bank Adjusts Hims & Hers Health Price Target to $16 From $14, Maintains Hold Rating	May. 07	MT
Social Buzz: Wallstreetbets Stocks Mixed Pre-Bell Monday; Palantir to Advance, Trump Media & Technology Group to Decline	May. 06	MT
Hims & Hers Health Insider Sold Shares Worth $4,200,307, According to a Recent SEC Filing	May. 06	MT
Seaport Global Starts Hims & Hers Health With Buy Rating	Apr. 26	MT
Jefferies Downgrades Hims & Hers Health to Hold From Buy, Cuts Price Target to $15 From $17	Apr. 16	MT
Canaccord Genuity Initiates Coverage on Hims & Hers Health With Buy Rating, $20 Price Target	Apr. 10	MT
Hims & Hers Health Insider Sold Shares Worth $823,055, According to a Recent SEC Filing	Mar. 22	MT
Tigress Financial Boosts Price Target on Hims & Hers Health to $19 From $15, Cites Move to Accelerated Growth Phase, Keeps Buy Rating	Mar. 01	MT
Piper Sandler Adjusts Price Target on Hims & Hers Health to $11 From $9, Maintains Neutral Rating	Feb. 27	MT
Deutsche Bank Adjusts Hims & Hers Health Price Target to $14 From $8, Maintains Hold Rating	Feb. 27	MT
Truist Securities Adjusts Price Target on Hims & Hers Health to $13 From $10, Keeps Hold Rating	Feb. 27	MT
Leerink Partners Initiates Coverage on Hims & Hers Health With Market Perform Rating, $10 Price Target	Feb. 26	MT
Tigress Financial Raises Price Target on Hims & Hers Health to $15 From $14, Maintains Buy Rating	Jan. 05	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Hims & Hers Health, Inc.

Equities

HIMS

US4330001060

Analyst Reco.

Filters